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Materials and Methods  
Buffer and media recipe for protein expression and yeast-two-hybrid experiments 
TBM-5052 
1.2% [wt/vol] tryptone, 2.4% [wt/vol] yeast extract, 0.5% [wt/vol] glycerol, 0.05% [wt/vol] D-
glucose, 0.2% [wt/vol] D-lactose, 25 mM Na2HPO4, 25 mM KH2PO4, 50 mM NH4Cl, 5 mM 
Na2SO4, 2 mM MgSO4, 10 μM FeCl3, 4 μM CaCl2, 2 μM MnCl2, 2 μM ZnSO4, 400 nM CoCl2, 
400 nM NiCl2, 400 nM CuCl2, 400 nM Na2MoO4, 400 nM Na2SeO3, 400 nM H3BO3 
 
Lysis buffer 
20 mM Tris, 300 mM NaCl, 20 mM Imidazole, pH 8.0 at room temperature 
 
Wash buffer 
20 mM Tris, 300mM NaCl, 30 mM Imidazole, pH 8.0 at room temperature 
 
Elution buffer 
20 mM Tris, 300 mM NaCl, 250 mM Imidazole, pH 8.0 at room temperature 
 
TBS buffer 
20 mM Tris pH 8.0, 100 mM NaCl 
 
YPAD buffer 
Peptone 20 g/L, yeast extract 10 g/L, Adenine hemisulfate 10 µg/L, dextrose (20 g/L) 
 
C-Trp-Ura-Leu-His+Adenine hemisulfate+Glucose 
Yeast nitrogen base w/o amino acids (6.7 g/L), synthetic DO media (-Leu/-His/-Trp/-Ura) (1.4 g/L), 
dextrose (20 g/L), adenine hemisulfate (10 µg/L) 
Construction of synthetic genes 
For the expression of proteins in E.coli, synthetic genes were ordered from Genscript Inc. 
(Piscataway, N.J., USA) and delivered in pET21-NESG E. coli expression vector, inserted 
between the NdeI and XhoI sites. For each expression construct, a hexahistidine tag followed by 
a tobacco etch virus (TEV) protease cleavage site (GSSHHHHHHSSGENLYFQGS) were added 
in frame at the N-terminus of the protein. A stop codon was introduced at the 3’ end of the protein 
coding sequence to prevent expression of the C-terminal hexahistidine tag in the vector.  
 
Genes for yeast-two-hybrid (Y2H) studies were cloned into plasmids bearing the GAL4 DNA-
binding domain (poDBD) and the GAL4 transcription activation domain (poAD) (53). Input proteins 
were cloned into plasmids V510 (uracil auxotrophic selection marker) and MX1 (bleomycin 
selection marker). Genes were expressed under the control of ADH1 promoters.  
 
Genes for NanoBiT assay were ordered from Genscript Inc. (Piscataway, N.J., USA) and were 
synthesized and cloned into one or more of the following vectors: pJL1, pJL1-lgBiT, pJL1-smBiT, 
pJL1-lgBiT-sfGFP, pJL1-smBiT-sfGFP, or pJL1-sfGFP. NanoBiT constructs were designed with 
a c-terminal fusion of either the smBiT or lgBiT fusion partner (114 and 11s respectively (40), for 
sequences see Table S1) with a 15 amino acid linker (GGSGGGGSGGSSSGG) separating the 
inserted gene and the fusion partner. Where specified, genes were also fused to the c-terminus 
of sfGFP separated by a 30 amino acid linker (GGGSGSx5). Genes were expressed using a T7 
promoter in cell-free protein synthesis. 
  
The fluorescence-reporting yeast two-hybrid-like assay was constructed using hierarchical golden 
gate assembly (54). Split transcription factor modules ((14), ZF43_8 and p43_8(8x)) and DHDs 
were domesticated as parts using PCR amplification or gBlocks (IDT). The progesterone 
responsive transcription factor (Z3PM) and cognate promoter (pZ3) were domesticated using 
PCR ((55), e.g. Addgene #87944 and #89195, respectively). All other promoters and terminators 
were taken from (3). Transcriptional units were assembled into cassette vectors and multi-
transcriptional units were assembled into integration vectors for insertion into the yeast genome 
at the indicated loci (see “Progesterone-responsive yeast strain construction and growth media”).  
Protein expression 
Plasmids were transformed into chemically competent E. coli expression strain Lemo21(DE3) 
(New England Biolabs) for protein expression. Following transformation and overnight growth, 
single colonies were picked from agar plates into 5 ml Luria-Bertani (LB) medium containing 100 
μg/mL carbenicillin (for pET21-NESG vectors) with shaking at 225 rpm for 18 hours at 37°C. 
Proteins were expressed using the autoinduction method (56): starter cultures were further diluted 
into 500 ml TBM-5052 containing 100 μg/mL carbenicillin, and incubated with shaking at 225 rpm 
for 24 hours at 37°C. 
Affinity purification 
E. coli cells were harvested by centrifugation at 5000 rcf for 15 minutes at 4°C and the pellet 
resuspended in 18 ml lysis buffer. EDTA-free cocktail protease inhibitor (Roche), lysozyme, and 
DNAse were added to the resuspended cell pellet, followed by cell lysis via sonication at 70% 
power for 5 minutes. Lysates were clarified by centrifugation at 4°C and 18,000 rpm for 45 minutes 
and applied to columns containing Ni-NTA (Qiagen) resin pre-equilibrated with lysis buffer. The 
column was washed two times with 5 column volumes (CV) of wash buffer, followed by 5 CV of 
elution buffer buffer for protein elution.  
Size-exclusion chromatography (SEC) 
Eluted proteins were buffer exchanged into lysis buffer. N-terminal hexahistidine tags were 
removed with TEV protease cleavage overnight at room temperature, at a ratio of 1 mg TEV for 
100 mg of protein. After TEV cleavage, sample was passed over a fresh Ni-NTA column and 
washed with 1.5 CV of lysis buffer, collecting flow through. The resulting proteins were purified by 
SEC using a Superdex 75 10/300 increase column (GE Healthcare) in TBS buffer.  
Circular dichroism (CD) measurements 
Circular dichroism (CD) wavelength scans (260 - 195 nm) and temperature melts (25 - 95 °C) 
were performed using an AVIV model 420 CD spectrometer, with protein samples diluted to 0.25 
mg/ml in PBS pH 7.4 in a 0.1-cm cuvette. Temperature melts were carried out at a heating rate 
of 4 °C/min and monitored by the change in ellipticity at 222 nm. 
 
GdmCl titrations were performed on a JASCO model J-1500 with automated titration apparatus 
in PBS pH 7.4 at 25 °C, with protein concentrations between 0.08 mg/ml to 0.025 mg/ml in a 1-
cm cuvette with stir bar. Each titration consisted of at least 34 evenly distributed GdmCl 
concentration points up to 7.4 M with 30 seconds of mixing time for each step. Titrant solution 
consisted of the same concentration of protein in PBS and GdmCl. 
CD data analysis and model fitting 
Folding free energies were obtained by fitting equilibrium denaturation data. Fused hairpin 
constructs had biphasic unfolding transitions, indicating the existence of an intermediate on their 
respective energy landscapes. Since native MS showed that Linker 0, Linker 2, Linker 6, and 
Linker 12 were almost exclusively monomeric in buffer (figure S3), it was concluded that these 
intermediates were partially folded monomeric species. Thus, the chemical denaturation data of 
these proteins was fitted to a unimolecular 3-state model: 
 
𝑁 ⇔  𝐼 ⇔  𝐷 
 
where 𝑁 represents the fully folded state, 𝐼 a partially folded intermediate, and 𝐷 the denatured 
state. The fraction of each species can be written as a function of 𝐾1 = [𝐼]/[𝑁] and 𝐾2 = [𝐷]/[𝐼], 
the equilibrium constants for the first and second transitions respectively: 
 
𝑓𝑁 = (1 + 𝐾1 + 𝐾1 ⋅ 𝐾2)
−1 












In the context of equilibrium chemical denaturation experiments, the free energy of unfolding is a 
linear function of denaturant concentration: 
 
𝛥𝐺[𝑑𝑒𝑛] = 𝛥𝐺𝑏𝑢𝑓𝑓𝑒𝑟 − 𝑚 ⋅ [𝑑𝑒𝑛] 
 
where𝛥𝐺[𝑑𝑒𝑛]represents the free energy of the system at a given concentration of denaturant, 
𝛥𝐺𝑏𝑢𝑓𝑓𝑒𝑟 is the corresponding free energy change in the absence of denaturant, and 𝑚 is a 
constant of proportionality that relates to the change in solvent-accessible surface area upon 
unfolding (𝛥𝑆𝐴𝑆𝐴). Thus, the effect of denaturants on the equilibrium constant relating to each 
transition can be written as a function of its free energy difference in buffer, and a specific m-
value: 
𝐾1 = 𝑒𝑥𝑝(








By combining these expressions with the definitions for 𝑓𝑁 , 𝑓𝐼 , 𝑓𝐷, the fractional distribution of each 
species can be expressed as a function of denaturant concentration, and the free energy change 
corresponding to each transition (in buffer). Finally, for an ensemble spectroscopic technique such 
as CD, the observed signal (the dependent variable) as a function of denaturant concentration 
(the independent variable) can be expressed as a linear combination of the spectroscopic signals 
corresponding to each species, weighed by their fractional contribution to the ensemble: 
 
𝑀𝑅𝐸222𝑛𝑚 = 𝑓𝑁 ⋅ 𝑀𝑅𝐸𝑁 + 𝑓𝐼 ⋅ 𝑀𝑅𝐸𝐼 + 𝑓𝐷 ⋅ 𝑀𝑅𝐸𝐷 
 
Where 𝑀𝑅𝐸𝑁 , 𝑀𝑅𝐸𝐼 , 𝑀𝑅𝐸𝐷represent the spectroscopic signatures (baselines) for the native, 
intermediate, and denatured states respectively. This equation was used to fit chemical 
denaturation data for the different linker proteins, and the fitted parameters are reported in Table 
S3. For Linker 24 in buffer, native MS revealed a significant proportion of dimer (Table S4). 
Therefore, this model is not entirely appropriate for describing the unfolding, and the fitted values 
for this construct should be interpreted with care. Nevertheless, denaturation performed at 
different concentrations of protein revealed that the position of the second transition was 
concentration-independent, and thus unimolecular. For this event, the model holds.  
 
The total m-values for these linked hairpins were found to be around 3 kcal mol-1 M-1. It has been 
shown that m-values correlate with 𝛥𝑆𝐴𝑆𝐴 of unfolding (57). For the folded state, 𝑆𝐴𝑆𝐴 was 
estimated from the structures of DHDs (32) using PyMOL to be 8800 Å2. For the unfolded state, 
𝑆𝐴𝑆𝐴 was estimated using ProtSA (58, 59), and is about 20,000 Å2. Thus, 𝛥𝑆𝐴𝑆𝐴 for the 
unimolecular unfolding of a fused hairpin should be around 11,000 Å2, which would have a 
predicted m-value of 3.3. This number is in close agreement with the fitted parameters reported 
here, in line with the notion that the folded state for these linker proteins has a four helix bundle 
topology.   
Small Angle X-ray Scattering (SAXS) 
Protein samples were purified by SEC in 25 mM Tris pH 8.0, 150 mM NaCl and 2% glycerol; 
elution fractions preceding the void volume of the column were used as blanks for buffer 
subtraction. Scattering measurements were performed at the SIBYLS 12.3.1 beamline at the 
Advanced Light Source. The sample-to-detector distance was 1.5 m, and the X-ray wavelength 
(λ) was 1.27 Å, corresponding to a scattering vector q (q = 4π sin θ/λ, where 2θ is the scattering 
angle) range of 0.01 to 0.3 Å−1. A series of exposures were taken of each well, in equal sub-
second time slices: 0.3-s exposures for 10 s resulting in 32 frames per sample. For each sample, 
data were collected for two different concentrations to test for concentration-dependent effects; 
‘low’ concentration samples ranged at 2.5 mg/ml and ‘high’ concentration samples at 5 mg/ml. 
Data were processed using the SAXS FrameSlice online serve and analysed using the ScÅtter 
software package (35, 60). The FoXS online server (61, 62) was used to compare experimental 
scattering profiles to design models and calculate quality of fit (χ) values. 
Yeast two-hybrid assay for logic gates 
Chemically competent cells of yeast strain PJ69-4a (MATa trp1-901 leu2-3,112 ura3-52 his3-200 
gal4(deleted) gal80(deleted) LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ) were transformed 
with the appropriate pair of plasmids containing DNA binding domains (DBD) or activation 
domains (AD), using the LiAc/SS carrier DNA/PEG method (63). For two input CIPHR logic gates, 
genes encoding the input proteins (together with selection markers) were genetically integrated 
into either or both of the Ura3 locus (uracil auxotrophic selection marker) or the YCR043 locus 
(bleomycin selection marker). In the case of three input CIPHR logic gates, genes encoding two 
input proteins were genetically integrated as described, with the additional input cloned 
downstream of either the AD or DBD plasmid, separated by a p2a and nuclear localization 
sequence (GSGATNFSLLKQAGDVEENPGPGDKAELIPEPPKKKRKVELGTA). The p2a 
sequence ensures translational cleavage to make the additional input protein a separate protein. 
The selection of transformed yeast cells was performed in synthetic dropout (SDO) medium 
lacking tryptophan and leucine for 48 h with shaking at 1,000 r.p.m. at 30 °C. The resulting culture 
was diluted 1:100 and grown for 16 h in fresh SDO medium lacking tryptophan and leucine, before 
being diluted 1:100 in fresh SDO medium lacking tryptophan, leucine and histidine. The culture 
was incubated with shaking at 1,000 r.p.m. at 30 °C. As it is necessary to bring the DBD and the 
transcription activation domain into proximity for the growth of yeast cells in medium lacking 
histidine, successful activation of logic gates was indicated by the growth of yeast cells (64, 65). 
The optical density of yeast cells was recorded at 24 h, 48 h, and 72 h. 
Native MS of individual proteins 
Sample purity and integrity were determined by online buffer exchange MS using an UltiMate 
3000 HPLC coupled to an Exactive Plus EMR Orbitrap instrument (Thermo Fisher Scientific) that 
was modified to incorporate a quadrupole mass filter and allow for surface-induced dissociation 
(66). Between 10 and 100 pmol protein was injected and online buffer exchanged to 200 mM 
ammonium acetate (AmAc) by a self-packed buffer exchange column (P6 polyacrylamide gel, 
BioRad) at a flow-rate of 100 µL per min. Data were deconvoluted with UniDec (version 3.1.1) 
(67) and are shown in Table S4. 
Native MS titration assay and data analysis 
Titration assay: Protein concentrations were determined based on UV absorbance at 280 nm with 
a NanodropTM 2000c spectrophotometer (Thermo Fisher Scientific). Mixtures for titration were 
prepared as outlined in Supplementary Table 5. Other mixtures are mixed with a final monomer 
concentration at 10 µM for each component. Proteins were incubated at 75 °C for 30 min in the 
presence of 5 M guanidinium hydrochloride to ensure complete denaturation. The denatured 
proteins were subsequently refolded into 200 mM AmAc by dialysis using Pierce™ 96-well 
Microdialysis Plate, 3.5K MWCO (ThermoFisher Scientific). 50 µL of each sample was loaded 
into individual microdialysis devices with 1.6 mL 200 mM AmAc in each well. The buffer was 
changed 8 times over a total dialysis time of 36 hours at room temperature. 12.5, 25, and 50 fold 
dilutions in 200 mM AmAc were prepared. Dilutions were measured in triplicate by flow-injecting 
5 µL into an Exactive Plus EMR Orbitrap instrument (Thermo Fisher Scientific) with 200 mM AmAc 
as flowing carrier stream. Mass spectra were recorded for 1,000 – 8,000 m/z at 17,500 resolution 
as defined at 200 m/z. The injection time was set to 200 ms for 1-in AND and 3-in AND titrations, 
and 150 ms for 2-in AND titrations. Voltages applied to the transfer optics were optimized to allow 
ion transmission while minimizing unintentional ion activation. Complex formations were observed 
and are shown in Table S6. Dilution series of individual proteins were also measured to ensure 
for a linear correlation between signal intensities and protein concentration (Table S7).  
 
Data analysis: All mass spectra were deconvoluted and processed using Intact Mass software 
(Protein Metrics, Cupertino, CA). Software default deconvolution parameters were used with the 
exception of minimum charge state (3) and mass range (5,000-80,000 Da). A list of theoretical 
masses for complexes up to pentamers was generated and included in the Intact Mass software 
for species assignments. Mass areas (in the mass “zero-charge” domain) were made by setting 
the mass area integration width to 12 Da. Mass areas of all species were exported from Intact 
Mass software using the reports function and then combined in Excel to generate titration curves. 
For Fig. 1G, each dot represents the total amount of any complexes that contain both 2 and 1’-2’ 
(e.g., 1:1’-2’:2, 1’-2’:2), normalized against its maximum value.    
Cell-Free extract preparation 
E. coli extracts were prepared following an established protocol in literature (41), with minor 
modifications. Briefly, three 150 mL BL21 StarTM (DE3) starter cultures were inoculated in LB from 
a glycerol stock and cultured in a 250 mL baffled flask at 37 °C for 16 hours. The starter cultures 
were used to inoculate 10 L of 2xYTPG media (16 g/L tryptone, 10 g/L yeast extract, 5 g/L sodium 
chloride, 7 g/L potassium phosphate dibasic, 3 g/L potassium phosphate monobasic, 18 g/L 
glucose) in a Sartorious BIOSTATⓇ Cplus fermenter at an initial OD600 of 0.08. The 2xYTP was 
prepared lacking glucose in 75% of the final volume and sterilized using the fermenter sterilization 
cycle. A 4x glucose solution was prepared and autoclaved separately, then added to the 
fermenter. Cells were cultured at 37 °C with an air flow rate of 8 SLPM and a 600 RPM stir rate. 
 
Cultures were grown until OD600 0.4-0.6, at which point the expression of T7 RNA polymerase 
was induced by the addition of IPTG to a final concentration of 0.5 mM. Cells were harvested at 
an OD600 of 3.0 via centrifugation at 5,000g for 10 minutes at 4 °C. Cell pellets were washed 
twice with 25 mL S30 buffer per 50 mL culture (10 mM Tris Acetate pH 8.2, 14 mM Magnesium 
Acetate, and 60 mM Potassium Acetate), centrifuging at 5,000g and 7,000g for the first and 
second washes respectively. Pellets were flash frozen in liquid nitrogen for storage. Pellets were 
thawed on ice for 1 hour and resuspended in 1 mL S30 buffer plus dithiothreitol per gram of cell 
mass (10 mM tris acetate pH 8.2, 14 mM magnesium acetate, and 60 mM potassium acetate, 2 
mM dithiothreitol). Cell suspensions were lysed using an Avestin EmulsiFlexⓇ-C3 Homogenizer 
at a lysis pressure of 23,000 PSI. Cell debris was separated via centrifugation at 10,000g for 10 
minutes, and the clarified lysate was collected, flash frozen in liquid nitrogen, and stored at -80 °C. 
Cell-Free Protein Synthesis reactions 
CFPS reactions utilized the PANOx-SP system (68). CFPS reactions were composed of the 
following reagents: 12 mM magnesium glutamate, 10 mM ammonium glutamate, 130 mM 
potassium glutamate, 1.2 mM ATP, 0.5 mM of each CTP, GTP, and UTP. 0.03 mg/mL folinic acid, 
0.17 mg/mL E. coli MRE600 tRNA (Roche 10109541001), 100 mM NAD, 50 mM CoA, 4 mM 
oxalic acid, 1 mM putrescine, 1 mM spermidine, 57 mM HEPES pH 7.2, 2 mM of each amino acid, 
33.3 mM PEP, 30% v/v E. coli extract, linear DNA templates were added to a final concentration 
of 3.33 µM, and the remainder water. For reactions co-expressing multiple proteins, each template 
was added to a final concentration of 0.83 µM. The preparation of these reagents has been 
described in detail elsewhere (69). All reaction components were assembled on ice and 12 µL 
reactions were pipetted into 1.5 mL microtubes. Reactions were allowed to proceed at 30 °C for 
20 hours. Protein expression yields were quantified by the addition of 10 uM of L-[14C(U)]-leucine 
(Perkin Elmer NEC279E250UC, 11.1GBq/mMole) to CFPS reactions, followed by scintillation 
counting of precipitated proteins (70). In cases where proteins were tagged with sfGFP, reaction 
yields were quantified by sfGFP fluorescence. A standard curve was prepared using radioactive 
leucine incorporation to measure sfGFP concentration and correlate with fluorescence. To 
quantify sfGFP fluorescence, 2 µL of a CFPS reaction was diluted in 48 µL of water in a Black 
Costar 96 Well Half Area Plate. Fluorescence was measured using a BioTek SynergyTM H1 plate 
reader with excitation and emission wavelengths of 485 and 528 respectively. In cases where 
proteins were tagged with sfGFP, reaction yields were quantified by sfGFP fluorescence. A 
standard curve was prepared using radioactive leucine incorporation to measure sfGFP 
concentration and correlate with fluorescence. To quantify sfGFP fluorescence, 2 µL of a CFPS 
reaction was diluted in 48 µL of water in a Black Costar 96 Well Half Area Plate. Fluorescence 
was measured using a BioTek SynergyTM H1 plate reader with excitation and emission 
wavelength of 485 and 528 nm respectively. 
Linear templates for Cell-Free Protein Synthesis 
Plasmid constructs were amplified via PCR using the Q5 High-Fidelity DNA Polymerase and 
primers ACH113 (ctgagatacctacagcgtgagc) and ACH114 (cgtcactcatggtgatttctcacttg) to generate 
linear DNA templates for cell-free protein synthesis reactions. PCR products were purified using 
the Zymo Research DNA Clean & Concentrator-5 kits following the recommended protocol. 
NanoBiTⓇ reactions 
NanoBiTⓇ reactions were setup using the Promega Nano-GloⓇ Live Cell Assay System following 
the Promega NanoBiTⓇ Technical Manual with minor modifications. Working buffer was prepared 
by diluting the LCS Dilution Buffer 1:4 in 1x PBS pH 7.3. CFPS reactions were diluted to the 
desired final concentration in working buffer and allowed to equilibrate at room temperature for 
the desired amount of time. The Nano-GloⓇ Substrate was used at a 50x final dilution of the stock. 
Reactions were prepared at a final volume of 2 µL, and were dispensed into 384 well plates (Nunc 
267462) using the EchoⓇ 525 liquid handler (Labcyte Inc.). Plates were immediately sealed (Bio-
Rad MSB1001) and luminescence was monitored using a BioTek SynergyTM H1 plate reader. 
 
Equilibrium logic gates were assayed by co-expressing all gate components in CFPS. Co-
expressed logic gates were diluted 100-fold in working buffer and allowed to equilibrate for 72 
hours before measurement. Kinetics of the induced dimerization system was measured by diluting 
individually expressed reaction components in working buffer to the desired level. The association 
reaction contained NanoBiTⓇ fusion proteins at a final concentration of 10 nM and input protein 
serially diluted across a range of concentrations. Reaction luminescence was monitored 
immediately after mixing components. The NOR gate input titration was set up by first diluting 
CFPS reactions for each component in working buffer. The mixture of NanoBiTⓇ fusions was 
prepared at a concentration of 5 nM of each component. Input proteins were serially diluted in 
working buffer to reach the desired concentration range. Dilutions were equilibrated for 3 hours 
at room temperature to allow for association of the fusion proteins. Reactions were then set up 
by adding the appropriate volume of diluted input protein to the NanoBiTⓇ fusion mixture. This 
was then allowed to equilibrate for 16 hours at room temperature before measurement. NOR gate 
kinetics were measured by adding 5 nM each of the NanoBiT® fusion proteins and monitoring 
association. After 20 minutes, 112.5 nM of 1 was added to the reaction and again luminescence 
was monitored. 
 
T cell husbandry 
CD3+ human T cells were ordered fresh from healthy donors from AllCells. Cells were activated 
using anti-CD3/CD28 Dynabeads from Invitrogen (Cat# 11132D). Cells were maintained in X-
VIVO 15 media (Lonza, 04-418Q) with 10% FBS (HyClone Cat# SH30071), 2 mM Glutamax 
(Gibco Cat# 35050-061) and 1% penicillin-streptomycin (Cellgro, Cat# 30-001-CI) passed through 
a 0.22 um filter and supplemented with recombinant human IL-2 (Peprotech, 200-02) at a final 
concentration of 200U/mL. Cells were cultured in 37C w/ 5% CO2 humidified HeraCell incubators 
(Thermo Scientific). Cell counts were performed by 0.4% trypan blue dye exclusion (Invitrogen, 
T10282).  
 
Logic-gated control of TALE-KRAB repressors 
We utilized the TALE DNA recognition domain and the KRAB repressor domain from a potent 
and specific synthetic transcription factor repressor targeting TIM3 (51). Separated TALE DNA 
recognition domain and KRAB proteins each fused to obligate heterodimers using a 15 amino 
acid linker domain (GGGGGMDAKSLTAWS) retain activity comparable to the single chain TALE-
KRAB protein when separate mRNAs encoding these molecules are electroporated into T cells 
(51). Logic gated control of TALE-KRAB repressors was engineered by pairing separated TALE 
and KRAB components with different orthogonal heterodimer pairs (e.g. – 1 of the 1:1’ pair). 
Design sequences were ordered as gBlocks from IDT and ligated into the TALE backbones.  
 
In vitro transcription of repressors 
mRNA was produced from the sequence-confirmed plasmids using the T7 mScript™ Standard 
mRNA Production System (CELLSCRIPT, C-MSC100625). mRNA was purified using Agencourt 
RNAclean XP beads (Beckman Coulter Cat#A63947), and QC of mRNA was performed on a 
Fragment Analyzer Infinity (Agilent) using the standard RNA kit (DNF-471-1000).  
 
T cell electroporation 
mRNA encoding TALE-TFs or heterodimeric proteins and controls were electroporated into T 
Cells using the BTX ECM830 Square Wave electroporator from Harvard Apparatus. Cells were 
collected and spun down, washed twice in PBS, and resuspended at a concentration of 250,000 
cells per well in 100 ul of BTXpress high performance electroporation solution (Harvard 
Apparatus, Cat# 45-0805). Cells were then mixed with 1 ug of mRNA unless otherwise indicated 
and multichannel pipetted into MOS 96-Multi-Well Electroporation Plate_2mm (BTX, Cat# 45-
0450). 
 
Electroporation Settings: Choose Mode: LV; Set Voltage: 250 V; Set Pulse Length: 5 ms; Set 
Number of Pulses: 1; Electrode Type: BTX Disposable Cuvette (2mm gap); Desired Field 
Strength: 3000 V/cm. 
 
Following transfection, cells were gently pipetted into warm media in a 96-well 1 mL deep well 
block and placed in a humidified 37°C, 5 % CO2 incubator. GFP mRNA was always included as 
a control for transfection efficiency, and observed on the Cytoflex 24 hour following transfection. 
 
T Cell flow cytometry 
Cells were counted and a minimum of 100,000 cells were collected for analysis using flow 
cytometry on a CytoFlex S (Beckman Coulter, B75442). Cells were spun down in a 96-well V-
bottom plate (Corning, 3894) and washed once in 1x PBS before staining with fluorophore-
conjugated antibody diluted with 1X PBS. Staining proceeded for 30 minutes in the dark at room 
temperature. Following staining, cells were washed once with 1X PBS, spun down, and 
resuspended in 100-200 ul FACS buffer (2% heat-inactivated Fetal Bovine Serum (HyClone, 
SH30071.03), 1 mM EDTA (OmniPur, 4050) in 1X PBS, passed through a 0.22 um filter) for flow 
cytometry analysis. Antibody Brilliant Violet 421™ anti-human CD366 (Tim-3) Antibody 
(BioLegend, 345008) was used at a concentration of 1:50.  
Progesterone-responsive yeast strain construction and growth media 
The base S. cerevisiae strain used in all progesterone experiments was BY4741 (MATa his3Δ1 
leu2Δ0 met15Δ0 ura3Δ0). Successive transformations of this background strain with the multi-
transcriptional units encoding the fluorescence-based yeast two hybrid system (“Construction of 
synthetic genes”) were performed using a standard LiAc/PEG protocol (12). All yeast cultures 
were grown in YPD media (10 g/L Bacto Yeast Extract, 20 g/L Bacto peptone, 20 g/L dextrose) 
or SDC media (6.7 g/L Bacto-yeast nitrogen base without amino acids, 2 g/L complete supplement 
amino acid mix, 20 g/L dextrose). 
 
yGD390 (Fig. 1J, Fig. S4) pHTB2s-11’-NLS-ZF43_8-tADH1 --  
pRPL18B-7-NLS-VP16-tSSA1 --  
pZ3-7’-11-NLS (SV40)-tENO1::leu2, 
 
pZ3-Venus-tENO2 --  
p43_8(8x)-mScarlet-tPGK1::ura3,  
 
pPAB1-Z3PM(fixed)-tTDH1 --  
pPOP6-GEM-tENO2 -- HIS3(C. glabrata)::HO 
 
Yeast cell culture 
Three colonies from the transformation of the fluorescence-based yeast two-hybrid system were 
used to inoculate a 1 mL YPD culture in a 2 mL 96 well storage block (Corning) to grow to 
saturation overnight (about 16 hours). 
Progesterone induction 
Saturated, overnight culture was diluted 1:500 in SDC and 450ul were aliquoted into individual 
wells of a new 2 mL 96 well storage block for a two hour outgrowth at 30 °C and 900 r.p.m. in a 
Multitron shaker (Infors HT). A Progesterone (Fisher Scientific) gradient was prepared at a 10x 
concentration by making the appropriate dilutions into SDC from a 3.2 mM stock solution. After 
the two hour outgrowth, 50ul of progesterone inducer was added to the corresponding wells of 
the 96 well block and the block was returned to the shaker for six hours of post-induction growth 
before measurement by flow cytometry. 
Yeast cell flow cytometry 
Measurement of fluorescent protein reporter expression was performed with a BD LSRFortessa 
flow cytometer (BD Biosciences) equipped with a high-throughput sampler. After the specified 
induction duration, cultures were diluted 1:1 in fresh SDC for running through the high-throughput 
sampler, such that 3,000–10,000 events per well were collected. YFP (Venus) fluorescence was 
measured using the FITC channel and RFP (mScarlet) was measured using the PE-CF594 
channel. Values were calculated on the height measurement and normalized to cell size by 
dividing by side scatter height (SSC-H). All analysis was performed in Python 3.7 using the 
package FlowCytometryTools and custom scripts.  
Data Deposition 
Raw data from native MS experiments has been deposited to 
http://files.ipd.uw.edu/pub/de_novo_logic_2019/190522_native_ms_raw.zip  
Supplementary Text 
Thermodynamic Modeling of Cooperativity 
 
 
For an induced dimerization system involving proteins A, A’-B, and B’, a stoichiometric excess 
(N>>1) of the A’-B protein results in partially assembled dimeric complexes if the binding is non-
cooperative, but fully assembled trimeric complexes if the binding is cooperative. 
 
We model the cooperatively induced dimerization system at thermodynamic equilibrium. Shown 
below, assuming a ‘closed’ state for A’-B, where the binding interfaces are buried within the four-
helix bundle, the binding of A’-B to either A or B’ helix hairpins needs to overcome an energy 
barrier of transitioning from the ‘closed’ to ‘open’ state (ΔGopen). Therefore the free energy of 
binding between A’-B to to A or B’ can be expressed as ΔGA:A’ - ΔGopen and ΔGB:B’ - ΔGopen, 
respectively, where ΔGA:A’ and ΔGB:B’ represent the free energy of binding between the cognate 
pairs in the absence of the fusion. Once the A:A’-B or A-B’:B complexes form, subsequent binding 
can simply be represented by the binding between cognate heterodimers: ΔGA:A’ or ΔGB:B’. We 
also observed the presence of (A)2 and (B’)2 homodimers, therefore we added free energy terms 
describing such processes into the model (ΔGA:A or ΔGB’:B’). 
 
ΔG relates to equilibrium constants by ΔG=-RTlnK, and we further consider the system in terms 
of K. We make the simplifying assumption that the affinity of A'-B to either A or B' is identical (K1 
= [A:A'-B]/([A][A'-B]) = [A'-B:B']/([B][A'-B]). Finally, we define the cooperativity of the system, c, as 
the ratio between the equilibrium constants in the presence or absence of the other partner 
(c=KB:B'/K1=KA:A'/K1). For an entirely non-cooperative process (c=1), KB:B'=K1 and KA:A'=K1 i.e., the 
first binding event does not affect the affinity of the subsequent binding event. 
 
Since K1=exp(-(ΔGA:A’ - ΔGopen)/RT), rewriting the equation for c in terms of free energies leads to 
c=exp(ΔGopen)/RT. Therefore, the extent of cooperativity is solely determined by the magnitude of 
the free energy required to partially unfold/expose the buried binding interfaces of the dimerizer 
A'-B. 
 
We note that explicitly incorporating the equilibrium constants for homodimerization (KA:A and 
KB':B') only affect the absolute position of each equilibrium, but does not affect the magnitude of 
the cooperativity. Indeed, taking A as an example, the binding to the closed state becomes K1 * 
KA:A, and the binding to the open state becomes KA:A' * KA:A. Because KA:A is present in both the 
numerator and the denominator, they cancel out, and c remains purely defined by the relative 
magnitudes of K1 and KA:A'. 
 
 
We solved the following system of equations in Mathematica 11 (Wolfram Research, Inc.) to 
simulate the amount of A:A’-B:B’ at equilibrium as a function of the initial concentration of A’-B: 
 








𝐾1 =  
[𝐴: 𝐴′ − 𝐵]
[𝐴][𝐴′ − 𝐵]
 
𝐾1 =  
[𝐵′: 𝐴′ − 𝐵]
[𝐵′][𝐴′ − 𝐵]
 
𝐾𝐴:𝐴′  =  
[𝐴: 𝐴′ − 𝐵: 𝐵′]
[𝐴][𝐴′ − 𝐵: 𝐵′]
 
𝐾𝐵:𝐵′  =  
[𝐴: 𝐴′ − 𝐵: 𝐵′]
[𝐵′][𝐴: 𝐴′ − 𝐵]
 
[𝐴]𝑡𝑜𝑡  =  2 ∗ [𝐴2] + [𝐴] + [𝐴: 𝐴′ − 𝐵] + [𝐴: 𝐴′ − 𝐵: 𝐵′] 
[𝐵′]𝑡𝑜𝑡  =  2 ∗ [𝐵′2] + [𝐵′] + [𝐴′ − 𝐵: 𝐵′] + [𝐴: 𝐴′ − 𝐵: 𝐵′] 
[𝐴′ − 𝐵]𝑡𝑜𝑡  = [𝐴′ − 𝐵: 𝐵′] +  [𝐴: 𝐴′ − 𝐵′] + [𝐴: 𝐴′ − 𝐵: 𝐵′] 
 
We knew from previous native MS titration experiments that the equilibrium dissociation constants 
of cognate designed heterodimers (DHDs) is in the ~10 nM range (32), therefore KA:A’ = KB:B’ = 
0.1 nM-1. Varying values of K1 (and hence the cooperativity factor, c = KA:A’/K1) showed different 
responses of the amount of A:A’-B:B’ at equilibrium as a function of the initial concentration of A’-
B, as shown in Fig. 1C. 
 
We experimentally estimated K1 using native MS experiments. Mixing 10 μM of 1 and 1’-2’ 
resulted in no detectable amount of the 1:1’-2’ complex, suggesting very weak binding. The 
sensitivity of native MS places a lower-bound on the concentration of species that can be detected 
(0.0375 μM, Table S8). Using this value, a lower-bound for the affinity of 1:1’-2’ can be estimated 
(1/K1 ≥ 2.65 mM). This agrees with the value of 9.91 mM obtained by calculating the affinity based 
on the c value of 991,000 reported in Figure 1H.  
 
This thermodynamic modeling demonstrates that binding cooperativity can be achieved for an 
induced dimerization system through occlusion of the binding interfaces. We achieved this by 
fusing hairpins via a flexible linker, rationalizing that the spontaneous folding of these constructs 
would bury the interaction interfaces on the inside of a four helical bundle like topology. Formation 
of these structures is corroborated by: i) SAXS profiles that are consistent with DHDs structures, 
ii) m-values from chemical denaturation experiments consistent with ΔSASA for the unfolding of 
DHD topologies (Fig. S2, Table S3), and iii) ΔGopen < ΔGfolding, suggesting that exposing the binding 
interfaces requires partial unfolding of these fused constructs, but does not exceed the folding 





Figure S1. (A) Molecular implementation of the cooperative induced dimerization system, binding 
only occurs when all three components are present. (B) Size exclusion chromatography profiles 
of 1’-2’ variants with 0, 2, 6, 12, and 24 amino acids as the flexible linker connecting 1’ and 2’.  
  
Figure S2. GdnHCl equilibrium denaturation experiments monitored by CD at 222 nm for 1’-2’ 
designs with 0-, 2-, 6-, 12- and 24- residue linkers. For each plot, the top subplot shows the 
experimental data (circles) fitted to the 3-state unimolecular unfolding model (black line). The 
middle subplots show residuals to the fit, and the bottom subplots indicate the fraction of each 
species as a function of denaturant concentration. An approximation of helical content is also 
reported (second ordinate, based on the MRE value at 222 nm using the model of Muñoz & 
Serrano (71). All fitted parameters are reported in Table S3. ΔG and m-values are also reported 
in the title of each plot. ΔG represent the free energy change extrapolated to buffer. The 
corresponding m-values represent the denaturant sensitivity of each transition, and relate to the 
𝛥𝑆𝐴𝑆𝐴 associated with each event.    
 
Figure S3. Native MS signal intensity of the dimerizer 1’-2’ (6-residue linker), 1, and 2 against 
protein concentrations (see also Table S8). Equations for linear regression fits are displayed. All 
error bars are reported as standard deviations of n=3 independent replicates. 
 
Figure S4. Induction of RFP (mScarlet) expression by the “Induced Dimerization” system in 
Figure 1J, where the dimerizer species is measured by a separate, proxy “pZ3-YFP” (Venus) 
reporter. Dotted lines represent constitutive expression levels of YFP and RFP under the RPL18b 
promoter used to express the DBD and AD monomer species in Figure 1J. Maximal induction of 
the dimerizer/YFP (128 nM Progesterone) is about 5x the value of pRPL18b-YFP, indicating that 
the cooperative binding functions across a wide range of concentrations. All error bars are 




Figure S5. Binding affinity gradient from individual Y2H experiments. (A) The 8:8’ 
heterodimer binds more tightly than the homodimers of its monomers. (B) Binding affinity 
gradient among the monomers of 1:1’, 9:9’, and 10:10’ pairs. Cell growth was measured on 
different days across the rows but on the same day within each row, and not corrected against 
background growth.  
 
Figure S6. NanoBiT characterization of CIPHR logic gate components. (A) Specificity matrix 
for designs tested in the cell-free expression system. (B) Yeast two-hybrid specificity matrix for 
the same designs. (C) Kinetic measurements of induced dimerization gate at varying 
concentrations of the dimerizer input. (D) Kinetics of induced dimerization (with or without 335 nM 
dimerizer protein) in the first 30 minutes. (E) Kinetic measurements of NOR gate activation and 
subsequent deactivation via competitive binding upon addition of input (arrow). All error bars are 
reported as standard deviations of n=3 independent replicates. 
  
 
Figure S7. T cell KRAB-TALE characterization of CIPHR logic gate components. (A) 
Specificity matrix for designs tested in T cells. (B) Yeast two-hybrid specificity matrix for the same 
designs. (C) Expression level of TIM3 in T cells not treated with CIPHR logic gates.  
 
  
Table S1. Design Sequences. 
Amino acid sequences of all designs tested. Two versions of DHD 15 heterodimers were used 
here, with slight differences in the loop sequence. For simplicity they are all labeled 2 and 2', 
differentiated with an additional asterisk (*). See attached Supplementary Table 1.xlsx for 
design sequences and Vectors.zip for plasmid maps. 
  
Table S2. SAXS analysis statistics. 
Rg is the radius of gyration, Rc is the cross-sectional radius of gyration determined from Guinier 
fitting, and Px is the Porod exponent. The Rc value for most designs cluster around 12 Å, in a 
close agreement with design models. 
 

























13.00 12.00 21.54 21.06 4.2 63 12.46 3 
15B-
37B_linker12 
13.00 12.00 20.86 20.66 3.9 62 12.04 3 
15A 17.00 17.00 19.22 19.86 3.5 61 12.58 3.4 
37A 17.00 14.00 22.51 21.43 4.5 65 13.3 3.1 
15B-131A 8.30 7.60 20.67 20.91 4.1 65 12.26 2.8 
131B-37B 12.00 9.90 28.82 27.31 7.3 85 15.14 2.8 
131B-101A 12.00 11.00 21.14 21.35 4.4 65 13.72 3.1 
 
Table S3. CD data parameter fitting. 
Fitted parameters for equilibrium chemical denaturation. Errors represent fitting errors. 












13.5 (±0.7) 14.1 (±0.4) 15.7 (±0.5) 13.3 (±0.5) 14.1 (±0.8) 
𝒎𝟏 
(kcal mol-1 M-1) 
1.1 (±0.2) 1.0 (±0.1) 0.9 (±0.1) 0.75 (±0.05) 1.1 (±0.1) 
𝒎𝟐 
(kcal mol-1 M-1) 
1.8 (±0.1) 1.97 (±0.07) 2.22 (±0.08) 1.96 (±0.08) 2.0 (±0.1) 
𝒎𝒕𝒐𝒕 
(kcal mol-1 M-1) 
2.9 (±0.2) 3.0 (±0.1) 3.1 (±0.1) 2.71 (±0.09) 3.1 (±0.2) 
𝑴𝑹𝑬𝑵 
(deg cm2 dmol-1) 
-23,574 (±114) -27,561 (±84) -24,712 (±63) -33,849 (±131) -26,438 (±123) 
𝑴𝑹𝑬𝑰 
(deg cm2 dmol-1) 
-16,330 (±749) -18,139 (±540) -14,779 (±710) -17,362 (±1,158) -15,567 (±914) 
𝑴𝑹𝑬𝑫 
(deg cm2 dmol-1) 
-525 (±107) -785 (±82) -937 (±68) -1,104 (±99) -1,125 (±133) 
 
Table S4. Native MS spectra of individual designs.  
5 μL protein (10-100 pmol) were injected and detected by online buffer exchange coupled to an 
Exactive Plus EMR Orbitrap instrument. Spectra were deconvoluted by UniDec. Species and 
determined molecular weights are depicted. Signals corresponding to monomers are indicated by 






Table S5. Protein concentrations native MS titration experiments. 
Titration for Figure 1G 
Design concentration/ µM 
2 0 3 6 10 15 20 
1 10 10 10 10 10 10 
1’-2’ 10 10 10 10 10 10 
         
Titration for Figure 1H 
Design concentration/ µM 
2 10 10 10 10 10 10 10 10 
1 10 10 10 10 10 10 10 10 
1’-2’ 0 3 6 10 15 20 40 60 
         
Titration for Figure 1L 
Design concentration/ µM 
2 10 10 10 10 10 10 10 10 
1 10 10 10 10 10 10 10 10 
3-2’ 0 3 6 10 15 20 40 60 
1’-3’ 0 3 6 10 15 20 40 60 
         
Titration for Figure 1N 
Design concentration/ µM 
2 10 10 10 10 10 10 10 10 
1 10 10 10 10 10 10 10 10 
1’-4’ 0 3 6 10 15 20 40 60 
4-3’ 0 3 6 10 15 20 40 60 
3-2’ 0 3 6 10 15 20 40 60 
 
  
Table S6. Native MS spectra of complexes.  
Samples were prepared by mixing equimolar amounts of 1, 2, and the corresponding dimerizer(s) 
(i.e.1’-2’ for induced dimerization, 1’-3’ + 3-2’ for 2-in AND, linker 1’-4+ 4-3’+ 3-2’+ for 3-in AND). 
After denaturation, refolding and dialysis against 200 mM AmAc, the mixtures were diluted 12.5 
fold with 200 mM AmAc and 5 μL were flow-injected into an Exactive Plus EMR Orbitrap 
instrument. Spectra were deconvoluted by UniDec. Species and determined molecular weights 
are depicted. Signals corresponding to the 1-(dimerizer)n-2 complex are indicated by a red circle, 
free dimerizer is indicated by a yellow star.   

 
Table S7. Detailed native MS titration spectra of AND logic gates.  
Samples were prepared by mixing 10 µM 1 and 2 with 0 – 60 µM of (A) 1’-2’ with 0-residue linker, 
(B) 1’-2’ with 2-residue linker, (C) 1’-2’ with 6-residue linker, (D) 1’-2’ with 12-residue linker, (E) 
1’-2’ with 24-residue linker, (F) 1’-3’ + 3-2’, and (G) 1’-4+ 4-3’+ 3-2’. After denaturation, refolding 
and dialysis against 200 mM AmAc, the mixtures were diluted 12.5 fold with 200 mM AmAc and 
5 μL were flow-injected into an Exactive Plus EMR Orbitrap instrument. Signals corresponding to 
the full trimer complexes in (A) - (E), full tetramer complex in (F) and full pentamer complex in (G) 
are indicated by a red circle. Free dimerizer/ dimerizer complexes are indicated by a blue triangle. 
The spectra for each titration were normalized and stacked to visualize the change in complex 
abundance in dependency of added dimerizer(s). As indicated by a red arrow and dashed line, in 
(G) relative intensities for signals with m/z >4300 are magnified 4x, and in (E) relative intensities 
for signals with m/z >4200 are magnified 5x for m/z >4200 to help visualize formation of full 
complexes in the presence of the easily ionizable dimerizers. Lists of all identified and quantified 




Table S8. Native MS spectra of serial dilution experiments.  
Samples at 60 μM monomer concentration were prepared by denaturation, refolding and dialysis 
against 200 mM AmAc. Proteins were diluted to the indicated concentrations (4.8 µM to 0.0375 
µM). 5 μL (24 pmole to 0.1875 pmole) were flow-injected into an Exactive Plus EMR Orbitrap 
instrument. Spectra were deconvoluted by UniDec. Species and determined molecular weights 
are depicted. Signals corresponding to monomers are indicated by an orange circle, dimers are 
indicated by a red square. Total ion chromatograms (1000-8000 m/z) are depicted for flow-
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